Our accredited content is designed to impact patient health outcomes, by ensuring that it provides you with a learning experience that will positively impact your clinical practice, based on adult learning preferences and intuitive instructional design. All activities are developed in collaboration with leading faculty and education partners.
Three experts discuss data presented at COMy and EHA 2024 on BCMA-targeting agents in multiple myeloma.
Three experts discuss data presented at EHA and ISTH 2024 on the impact and management of ITP.
Haematology experts discuss the latest on novel therapies and treatment selection and sequencing in R/R FL
Multidisciplinary experts discuss the diagnosis and management of patients with systemic mastocytosis.
Three experts discuss data presented at COMy and EHA 2024 on BCMA-targeting agents in multiple myeloma.
Three experts discuss data presented at EHA and ISTH 2024 on the impact and management of ITP.
Haematology experts discuss the latest on novel therapies and treatment selection and sequencing in R/R FL
Multidisciplinary experts discuss the diagnosis and management of patients with systemic mastocytosis.
Multidisciplinary experts discuss the diagnosis and management of haemophagocytic lymphohistiocytosis (HLH)
Learn about investigational protein degradation and immunomodulatory therapies in multiple myeloma.
Watch haemato-oncology experts discuss updates in managing R/R mantle cell lymphoma with CAR T-cell therapy.
Watch haemato-oncology experts discuss updates in R/R follicular lymphoma, with a focus on CAR T-cell therapy.
touchHAEMATOLOGY is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.